AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24262397 — intervention group
Group type: COMPARATOR
Intervention: Sugared chewing gum
Number of subjects: 30
Study 21739700 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture compound anesthesia (Sibai ST 2, Xiaguan ST 7, Hegu LI 4, Zhigou TE 6 on left side; routine local anesthesia on right side)
Number of subjects: 61
Study 21739700 — intervention group
Group type: COMPARATOR
Intervention: Routine local anesthesia (both sides)
Number of subjects: 61
Study 21739700 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture compound anesthesia
Number of subjects: 61
Study 21739700 — intervention group
Group type: COMPARATOR
Intervention: Routine local anesthesia
Number of subjects: 61
Study 19454915 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Spirit intervention (25 visits)
Number of subjects: 167
Study 19454915 — intervention group
Group type: COMPARATOR
Intervention: Breast-feeding/nutrition education intervention (23 visits)
Number of subjects: 167
Study 16713542 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior 90 degrees fundoplication
Number of subjects: 79
Study 16713542 — intervention group
Group type: COMPARATOR
Intervention: Nissen fundoplication
Number of subjects: 79
Study 16713542 — intervention group
Group type: COMPARATOR
Intervention: Both procedures
Number of subjects: 79
Study 12495686 — intervention group
Group type: EXPERIMENTAL
Intervention: PMX-F treatment (N=15)
Number of subjects: 60
Study 12495686 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin treatment (N=15)
Number of subjects: 60
Study 12495686 — intervention group
Group type: EXPERIMENTAL
Intervention: PMX-F and teicoplanin in combination (N=20)
Number of subjects: 60
Study 12495686 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (N=10)
Number of subjects: 60
Study 10596307 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated hypertensive group
Number of subjects: 60
Study 10596307 — intervention group
Group type: COMPARATOR
Intervention: Normotensive group
Number of subjects: 60
Study 8729305 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative autologous donation (PAD)
Number of subjects: 45
Study 8729305 — intervention group
Group type: COMPARATOR
Intervention: Preoperative acute normovolaemic haemodilution with erythrocytapheresis (erythro)
Number of subjects: 45
Study 8729305 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative normovolaemic haemodilution (haemo)
Number of subjects: 45
Study 8729305 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative blood loss in erythro group
Number of subjects: 45
Study 8729305 — intervention group
Group type: COMPARATOR
Intervention: Correlation between haematocrit at d-1 and intraoperative bleeding
Number of subjects: 45
Study 1859070 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthpiece and mask (MM)
Number of subjects: 10
Study 1859070 — intervention group
Group type: COMPARATOR
Intervention: Mask only (M)
Number of subjects: 10
Study 1859070 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm (34 degrees C), humidified air
Number of subjects: 10
Study 1859070 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 4% lidocaine to the oral mucosa
Number of subjects: 10
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 msec stimulus interval
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 msec stimulus interval
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 sec preparatory interval
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sec preparatory interval
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaningful stimuli
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: Early occurring stimuli
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: Late occurring stimuli
Number of subjects: 14
Study 6615957 — intervention group
Group type: EXPERIMENTAL
Intervention: Unattended stimuli
Number of subjects: 14
Study 3925887 — intervention group
Group type: EXPERIMENTAL
Intervention: Bestatin combined with Mitomycin‐C, FT‐207
Number of subjects: 0
Study 3925887 — intervention group
Group type: COMPARATOR
Intervention: Control group (not given Bestatin)
Number of subjects: 0
Study 3925887 — intervention group
Group type: EXPERIMENTAL
Intervention: Bestatin
Number of subjects: 0
Study 31187126 — intervention group
Group type: EXPERIMENTAL
Intervention: Organized outreach using fecal immunochemical tests (FITs)
Number of subjects: 10820
Study 31187126 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10820
Study 30415298 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 µg once daily with theophylline 100 mg twice daily (Group I)
Number of subjects: 170
Study 30415298 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 18 µg once daily (Group II)
Number of subjects: 170
Study 27496687 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal surgery
Number of subjects: 183
Study 27496687 — intervention group
Group type: COMPARATOR
Intervention: Postnatal surgery
Number of subjects: 183
Study 24934893 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (10 μg/kg daily for 4 days)
Number of subjects: 86
Study 24934893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 24934893 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 86
Study 22211448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganganagar clay dust aerosol
Number of subjects: 20
Study 22211448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bikaner sand dust aerosol
Number of subjects: 20
Study 22211448 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaipur sand dust aerosol
Number of subjects: 20
Study 22211448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganganagar sand dust aerosol
Number of subjects: 20
Study 22211448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21122501 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Support Program (PSP)
Number of subjects: 81
Study 21122501 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 81
Study 18005144 — intervention group
Group type: EXPERIMENTAL
Intervention: rizatriptan 10 mg
Number of subjects: 94
Study 18005144 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 94
Study 15877874 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 0
Study 12889506 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortrans
Number of subjects: 94
Study 12889506 — intervention group
Group type: COMPARATOR
Intervention: bisacodyl
Number of subjects: 94
Study 9179834 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic information system (voice-interactive, physician-directed, 24h access via touch-tone telephone)
Number of subjects: 204
Study 9179834 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients not actively using the system)
Number of subjects: 204
Study 9179834 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic information system
Number of subjects: 204
Study 1662119 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B at doses ranging from 3.47 to 9.1 mg/m2
Number of subjects: 30
Study 1662119 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B at a recommended dose of 6.3 mg/m2
Number of subjects: 30
Study 1662119 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antiemetics including dexamethasone
Number of subjects: 30
Study 1662119 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids added to premedication regimen
Number of subjects: 30
Study 1662119 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B
Number of subjects: 30
Study 7073046 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxacillin 500 mg QID x 5 days
Number of subjects: 63
Study 7073046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 30501480 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided reflection educational session
Number of subjects: 62
Study 30501480 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 62
Study 30830377 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,5-anhydroglucitol
Number of subjects: 56
Study 30830377 — intervention group
Group type: EXPERIMENTAL
Intervention: norvaline
Number of subjects: 56
Study 30830377 — intervention group
Group type: EXPERIMENTAL
Intervention: L-aspartic acid
Number of subjects: 56
Study 26884590 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib (S) 800 mg daily
Number of subjects: 106
Study 26884590 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib + Everolimus (S + E) 800 mg + 5 mg daily
Number of subjects: 106
Study 24345385 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 6524
Study 24345385 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 6524
Study 24345385 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes
Number of subjects: 6524
Study 21988149 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen Calcium (200 mg) in three-layered gum tablet (1800 mg)
Number of subjects: 0
Study 21988149 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilized ternary complex containing 100 mg of Fn with PVP K(25)
Number of subjects: 0
Study 21988149 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen Calcium (100 mg) in chewing gum
Number of subjects: 0
Study 21988149 — intervention group
Group type: COMPARATOR
Intervention: Selected gum tablet
Number of subjects: 0
Study 19395079 — intervention group
Group type: EXPERIMENTAL
Intervention: Voglibose 0.2 mg three times a day (n=897)
Number of subjects: 1780
Study 19395079 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=883)
Number of subjects: 1780
Study 17175181 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene treatment
Number of subjects: 20
Study 17175181 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 20
Study 15892043 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine plus docetaxel (1250 mg/m2 twice daily on Days 1-14 plus docetaxel 75 mg/m2 on Day 1)
Number of subjects: 511
Study 15892043 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone (100 mg/m2 on Day 1)
Number of subjects: 511
Study 15892043 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine plus docetaxel
Number of subjects: 511
Study 15892043 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 511
Study 11845111 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-hormone replacement therapy (nonHRT) alternatives
Number of subjects: 0
Study 11845111 — intervention group
Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 0
Study 10521198 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication of H pylori
Number of subjects: 0
Study 10521198 — intervention group
Group type: COMPARATOR
Intervention: H pylori infection
Number of subjects: 0
Study 8954445 — intervention group
Group type: EXPERIMENTAL
Intervention: Case managed
Number of subjects: 0
Study 8954445 — intervention group
Group type: COMPARATOR
Intervention: Non-case managed
Number of subjects: 0
Study 1833122 — intervention group
Group type: EXPERIMENTAL
Intervention: four‐point profiles on 2 days per week
Number of subjects: 25
Study 1833122 — intervention group
Group type: EXPERIMENTAL
Intervention: four‐point profiles on 1 day per week
Number of subjects: 25
Study 1833122 — intervention group
Group type: EXPERIMENTAL
Intervention: two‐point profiles on every day of the week
Number of subjects: 25
Study 6343726 — intervention group
Group type: EXPERIMENTAL
Intervention: DES plus Cytoxan
Number of subjects: 188
Study 6343726 — intervention group
Group type: EXPERIMENTAL
Intervention: DES plus Emcyt
Number of subjects: 188
Study 6343726 — intervention group
Group type: COMPARATOR
Intervention: DES alone
Number of subjects: 188
Study 6343726 — intervention group
Group type: COMPARATOR
Intervention: DES/ORCH
Number of subjects: 188
Study 31178278 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intra-aortic balloon counterpulsation (IABC)
Number of subjects: 24
Study 31178278 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IABC)
Number of subjects: 24
Study 24726159 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin-C (MMC) 0.02% applied for 15 seconds
Number of subjects: 60
Study 24726159 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution applied for 15 seconds (Control)
Number of subjects: 60
Study 23264316 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone ER (20 mg)
Number of subjects: 0
Study 20938423 — intervention group
Group type: EXPERIMENTAL
Intervention: Klamath algae extract (Klamin®, 1600 g/day)
Number of subjects: 30
Study 20938423 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vanilla tablets)
Number of subjects: 30
Study 18794413 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (human) (Evicel) applied to one side during rhinoplasty
Number of subjects: 10
Study 18794413 — intervention group
Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 10
Study 16172704 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mini-Mental State Examination (mo‐MMSE)
Number of subjects: 253
Study 16172704 — intervention group
Group type: COMPARATOR
Intervention: Adapted Mini-Mental State Examination (ad‐MMSE)
Number of subjects: 253
Study 12376581 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg/day, 2 divided doses)
Number of subjects: 33
Study 12376581 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 33
Study 9456163 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (calcium channel blocker)
Number of subjects: 12
Study 9456163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9456163 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Isradipine and Placebo)
Number of subjects: 12
Study 8582071 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral cannulated Merocel nasal packs
Number of subjects: 40
Study 8582071 — intervention group
Group type: COMPARATOR
Intervention: Non-cannulated Merocel nasal packs (Control)
Number of subjects: 40
Study 2930448 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety-signal technique (travelling towards the therapist in fear-inducing situations)
Number of subjects: 0
Study 2930448 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapist-assisted exposure
Number of subjects: 0
Study 1013850 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexoprenaline
Number of subjects: 10
Study 1013850 — intervention group
Group type: COMPARATOR
Intervention: Fenoterol
Number of subjects: 10
Study 1013850 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 10
Study 1013850 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 10
Study 1013850 — intervention group
Group type: COMPARATOR
Intervention: All drugs
Number of subjects: 10
Study 30910569 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (10 minutes to the quadriceps)
Number of subjects: 78
Study 30910569 — intervention group
Group type: COMPARATOR
Intervention: Sham joint mobilisation (control group)
Number of subjects: 78
Study 28555198 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous walking and isometric handgrip exercise (WHG)
Number of subjects: 48
Study 28555198 — intervention group
Group type: COMPARATOR
Intervention: Walking (WLK)
Number of subjects: 48
Study 28555198 — intervention group
Group type: COMPARATOR
Intervention: Isometric handgrip exercise (IHG)
Number of subjects: 48
Study 28555198 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 48
Study 25698076 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine-assisted learning (EAL) for 5 weeks
Number of subjects: 0
Study 25698076 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 0
Study 24062815 — intervention group
Group type: EXPERIMENTAL
Intervention: Elaborate feedback and audience response system (ARS)
Number of subjects: 0
Study 24062815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no elaborate feedback)
Number of subjects: 0
Study 21592127 — intervention group
Group type: COMPARATOR
Intervention: Michigan Model for Health (MMH) curriculum, 24 lessons in grade 4 over 12 weeks and 28 lessons in grade 5 over 14 weeks, taught by trained teachers.
Number of subjects: 2512
Study 21592127 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2512
Study 19630553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Caring (NC) - three counseling sessions
Number of subjects: 341
Study 19630553 — intervention group
Group type: EXPERIMENTAL
Intervention: All three interventions (NC, SC, CC)
Number of subjects: 341
Study 19630553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Caring (NC) and Combined Caring (CC)
Number of subjects: 341
Study 19630553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Caring (NC) and Self-Caring (SC)
Number of subjects: 341
Study 19630553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Caring (NC), Combined Caring (CC), and Control
Number of subjects: 341
Study 19630553 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 341
Study 17016841 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/kg glucose feed
Number of subjects: 0
Study 17016841 — intervention group
Group type: COMPARATOR
Intervention: Water feed (Control)
Number of subjects: 0
Study 14626626 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin treatment (combination of vitamins B6, B12, and folic acid)
Number of subjects: 62
Study 14626626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 11061656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU) in combination with stavudine and didanosine
Number of subjects: 102
Study 11061656 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine/stavudine/HU
Number of subjects: 102
Study 11061656 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyurea (HU)
Number of subjects: 102
Study 11061656 — intervention group
Group type: COMPARATOR
Intervention: Stavudine plus didanosine
Number of subjects: 102
Study 9557073 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with systemic sclerosis (SSc) with normal thyroid function
Number of subjects: 21
Study 9557073 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with systemic sclerosis (SSc) with overt or latent hypothyroidism
Number of subjects: 21
Study 9557073 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21
Study 8168532 — intervention group
Group type: EXPERIMENTAL
Intervention: HsmtSSB protein
Number of subjects: 0
Study 8168532 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutated HsmtSSB (Trp68 replaced by threonine and tyrosine)
Number of subjects: 0
Study 3128572 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg natural progesterone i.m. daily from the day of oocyte retrieval onwards
Number of subjects: 168
Study 3128572 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural progesterone in combination with oestradiol valerate
Number of subjects: 168
Study 3128572 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG supplements
Number of subjects: 168
Study 3128572 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial biopsies from patients who did not undergo embryo replacement
Number of subjects: 168
Study 31477371 — intervention group
Group type: EXPERIMENTAL
Intervention: High Risk Social Challenge Task (HiSoC)
Number of subjects: 102
Study 31477371 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls (HC)
Number of subjects: 102
Study 29606522 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent and adjuvant temozolomide chemotherapy
Number of subjects: 62
Study 29606522 — intervention group
Group type: EXPERIMENTAL
Intervention: Unacceptable variations
Number of subjects: 62
Study 28138828 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel combined with resminostat (DR) therapy
Number of subjects: 117
Study 28138828 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 117
Study 26427307 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance alone (Group A)
Number of subjects: 50
Study 26427307 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound with nerve stimulation guidance (Group B)
Number of subjects: 50
Study 23592678 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 kcal/session exercise
Number of subjects: 141
Study 23592678 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 kcal/session exercise
Number of subjects: 141
Study 23592678 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control
Number of subjects: 141
Study 21291506 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ECV (34(0/7) to 35(6/7) weeks of gestation)
Number of subjects: 1543
Study 21291506 — intervention group
Group type: COMPARATOR
Intervention: Delayed ECV (at or after 37(0/7) weeks of gestation)
Number of subjects: 1543
Study 19242711 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified radiofrequency-assisted uvulopalatoplasty (MRAUP)
Number of subjects: 60
Study 19242711 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency-assisted uvulopalatoplasty (RAUP)
Number of subjects: 60
Study 16480565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy group programme for social phobia (10 sessions)
Number of subjects: 112
Study 15615549 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular brachytherapy (EVBT)
Number of subjects: 335
Study 15615549 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (1 g/d)
Number of subjects: 335
Study 11451263 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-limited treadmill tests at one year after CR
Number of subjects: 1678
Study 11451263 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-limited treadmill tests at three years after CR
Number of subjects: 1678
Study 11451263 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-limited treadmill tests at five years after CR
Number of subjects: 1678